TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

where's keith, page-7

  1. resourced
    2,243 Posts.
    lightbulb Created with Sketch. 109
    clock Created with Sketch.
    28/10/11
    11:11
    Post #: 9206002
    No , it would not be insider trading. However, I do not see how they could withold the report consistently with their continuous disclosure obligations. The results would not be commercial in confidence between TIS and any potential commercial partner.
    TIS Price at posting: 59.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

STX Strike reports flow test success at 100% owned Walyering-7
right-arrow Created with Sketch.
NEWS Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
right-arrow Created with Sketch.
NEWS A Super PITch is key in the competition for capital
right-arrow Created with Sketch.
SS1 Sun Silver hits silver grades above 200g/t in early-stage portable scanner analysis
right-arrow Created with Sketch.
NXG Cost blow-out for Rook I uranium project sees share plummet for NexGen
right-arrow Created with Sketch.
MGU Collaboration in a green (steel) future the focus for Magnum and Saudi partners
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.